Translational disease interpretation with molecular networks
- Equal contributors
Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, E-28029 Madrid, Spain
Genome Biology 2009, 10:221 doi:10.1186/gb-2009-10-6-221Published: 29 June 2009
Molecular networks are being used to reconcile genotypes and phenotypes by integrating medical information. In this context, networks will be instrumental for the interpretation of disease at the personalized medicine level.